Clinical Trial Update: An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]

View source ↗

Summary

Exploratory Phase 1 clinical trial evaluating YTS109 Cell for relapsed/refractory autoimmune diseases, including systemic lupus erythematosus and lupus nephriti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Antiphospholipid Syndrome
• Inflammatory Myopathy
• Lupus Nephritis
• Sjögren Syndrome
• Systemic Lupus Erythematosus

Drugs mentioned

• YTS109 cell (YTS109)

Snippet

Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. | Conditions: Systemic Lupus Erythematosus, Lupus Nephritis (LN) | Phase 1 | Status: RECRUITING